Glaukos rolls on with direct sales conversion for new-gen iStent
This article was originally published in Clinica
Executive Summary
US ophthalmology firm Glaukos is expanding its global direct sales presence, eschewing the distributor approach, as it rolls out its new generation micro-stent device for glaucoma patients.